15th of March 2024

Nutraceuticals as a revenue opportunity for pharma

At PharmaSynergy 2023 and Nicholas Hall 33rd European CHC Conference 2023, we discussed how nutraceuticals can present a new revenue opportunity for pharma companies.

In recent years, many pharma companies have turned to nutraceuticals in search of new revenue opportunities. They are increasingly tapping into the preventative segment by launching their own nutraceutical products and brands. What has led to this convergence and how are leaders utilizing the opportunity?

We have discussed this topic at PharmaSynergy and Nicholas Hall 33rd European CHC Conference in 2023. We have collected our insights in a presentation, which is available below.

what will you find in the presentation?

Download the presentation to discover:
  • why nutraceuticals could present a new revenue opportunity for pharma companies
  • which are the movements and important trends in the industry that suggest that the time to enter the nutraceutical market is now
  • how leading pharma companies are entering the nutraceutical market and addressing new target audiences with their launches

"*" indicates required fields

explore further.

Global CHC market trends talk with Amit Shukla
Global CHC market trends talk

We discussed how the global CHC market will evolve in the future with Amit Shukla, VP & Head of Global Consumer Health Consulting Services at IQVIA Consumer Health.

Pain – the next frontier in nutraceuticals

At the 34th European Nicholas Hall CHC Conference 2024 we discussed the white space in pain supplements and the trend leaders are increasingly addressing.

"*" indicates required fields

"*" indicates required fields

PharmaLinea © 2025